Presence Of M184I/V Mutation At Baseline More Prevalent Among Patients Newly Infected With HIV With History Of PrEP Use, Study Finds

Infectious Disease Advisor (12/21, Nye) reports, “Among individuals newly infected with HIV, the presence of an M184I/V mutation at baseline is more prevalent among those with a history of pre-exposure prophylaxis (PrEP) use.” While “PrEP is highly effective as an HIV prevention strategy, there is concern that its use in the period prior to HIV diagnosis may be associated with increased risk for acquired drug resistance.” The findings were published in Clinical Infectious Diseases.